Cargando…

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma

BACKGROUND: The introduction of immune checkpoint inhibitors has led to a survival benefit in patients with advanced melanoma; however data on the adoption of immunotherapy in the community are scarce. METHODS: Using the National Cancer Database, we identified 4725 patients aged ≥20 diagnosed with m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krimphove, Marieke J., Tully, Karl H., Friedlander, David F., Marchese, Maya, Ravi, Praful, Lipsitz, Stuart R., Kilbridge, Kerry L., Kibel, Adam S., Kluth, Luis A., Ott, Patrick A., Choueiri, Toni K., Trinh, Quoc-Dien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836520/ https://www.ncbi.nlm.nih.gov/pubmed/31699149 http://dx.doi.org/10.1186/s40425-019-0782-y

Ejemplares similares

Geographic Distribution of Racial Differences in Prostate Cancer Mortality
por: Fletcher, Sean A., et al.
Publicado: (2020)

RETRACTED: Comparing Long-Term Outcomes Following Radical and Partial Nephrectomy for cT1 Renal Cell Carcinoma in Young and Healthy Individuals
por: Tan, Wei Shen, et al.
Publicado: (2019)

Understanding Hospital-Level Patterns of Nonoperative Management for Low-risk Thyroid and Kidney Cancer
por: Koelker, Mara, et al.
Publicado: (2022)

Association of surgical approach and prolonged opioid prescriptions in patients undergoing major pelvic cancer procedures
por: Krimphove, Marieke J., et al.
Publicado: (2020)

Recovery from minimally invasive vs. open surgery in kidney cancer patients: Opioid use and workplace absenteeism
por: Krimphove, Marieke J., et al.
Publicado: (2021)

Association of Care at Minority-Serving vs Non–Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States
por: Cole, Alexander P., et al.
Publicado: (2019)

Cardiovascular toxicities associated with abiraterone compared to enzalutamide–A pharmacovigilance study
por: Cone, Eugene B., et al.
Publicado: (2021)

Mobile Health App for Prostate Cancer Patients on Androgen Deprivation Therapy: Qualitative Usability Study
por: Nabi, Junaid, et al.
Publicado: (2020)

Comparison of Hospital Readmission After Total Hip and Total Knee Arthroplasty vs Spinal Surgery After Implementation of the Hospital Readmissions Reduction Program
por: Ramaswamy, Ashwin, et al.
Publicado: (2019)

Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United States
por: Seisen, Thomas, et al.
Publicado: (2023)

Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic
por: Labaki, Chris, et al.
Publicado: (2021)

Disparities in Travel-Related Barriers to Accessing Health Care From the 2017 National Household Travel Survey
por: Labban, Muhieddine, et al.
Publicado: (2023)

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy
por: Cone, Eugene B., et al.
Publicado: (2022)

Assessment of Out-of-Pocket Costs for Robotic Cancer Surgery in US Adults
por: Nabi, Junaid, et al.
Publicado: (2020)

Data on Medicare eligibility and cancer screening utilization
por: Meyer, Christian P., et al.
Publicado: (2016)

Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers
por: Cone, Eugene B., et al.
Publicado: (2020)

Changes in anxiety and depression in patients with different income levels through the COVID-19 pandemic
por: Qian, Zhiyu, et al.
Publicado: (2023)

Disparities in selective referral for cancer surgeries: implications for the current healthcare delivery system
por: Sun, Maxine, et al.
Publicado: (2014)

Is Segmental Ureterectomy Associated with Inferior Survival for Localized Upper-Tract Urothelial Carcinoma of the Ureter Compared to Radical Nephroureterectomy?
por: Paciotti, Marco, et al.
Publicado: (2023)

Association of Variation in US County-Level Rates of Liver Surgical Resection for Colorectal Liver Metastasis With Poverty Rates in 2010
por: Molina, George, et al.
Publicado: (2023)

Pneumonia after Major Cancer Surgery: Temporal Trends and Patterns of Care
por: Trinh, Vincent Q., et al.
Publicado: (2016)

Addition of Interleukin-21 for Expansion of T-Cells for Adoptive Immunotherapy of Murine Melanoma
por: Zoon, Christine Kathryn, et al.
Publicado: (2015)

Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma
por: Klemen, Nicholas D., et al.
Publicado: (2016)

Investigating the racial gap in prostate cancer screening with prostate-specific antigen among younger men from 2012 to 2020
por: Qian, Zhiyu, et al.
Publicado: (2023)

Interaction between effector and memory cd8+ t cells enhances melanoma adoptive immunotherapy
por: Contreras, Amanda, et al.
Publicado: (2015)

ASO Author Reflections: How We Convey Empathy, Address Uncertainty, and Share Serious News: Challenges to Remote Surgical Care
por: Sokas, Claire, et al.
Publicado: (2021)

Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma
por: Ravi, Praful, et al.
Publicado: (2022)

National trends in hospital-acquired preventable adverse events after major cancer surgery in the USA
por: Sukumar, Shyam, et al.
Publicado: (2013)

Radical prostatectomy for high-risk prostate cancer | Opinion: YES
por: Reis, Leonardo O., et al.
Publicado: (2019)

Adoptive T Cell Immunotherapy for Cancer
por: Perica, Karlo, et al.
Publicado: (2015)

Immunotherapy: ADOPTIVE T CELL IMMUNOTHERAPY FOR SARS-COV-2
por: Henden, A., et al.
Publicado: (2023)

Adoptive Immunotherapy with Cl-IB-MECA-Treated CD8+ T Cells Reduces Melanoma Growth in Mice
por: Montinaro, Antonella, et al.
Publicado: (2012)

A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma
por: Labarriere, N., et al.
Publicado: (2013)

Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy
por: Ortenberg, R., et al.
Publicado: (2015)

Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma
por: Marmarelis, Melina E., et al.
Publicado: (2016)

Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors
por: Nuzzo, Pier Vitale, et al.
Publicado: (2020)

Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment
por: Delfanti, Gloria, et al.
Publicado: (2022)

Adoptive immunotherapy against ovarian cancer
por: Mittica, Gloria, et al.
Publicado: (2016)

Application Of Adoptive Immunotherapy In Ovarian Cancer
por: Yang, Siyu, et al.
Publicado: (2019)

Adoptive Immunotherapy beyond CAR T-Cells
por: Titov, Aleksei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_72950j075rnjsnpvg7jtqnvvt1